ORAI3 and breast cancer: Again, Orai3 overexpression, protects T47D cells against cell death inducers like cisplatin, fluorouracil, paclitaxel, staurosporin and thapsigargin, suggesting a role for Orai3 in breast cancer resistance to chemotherapeutics [43].